This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

The Lipid Research Clinics Program

JAMA. 1985;253(21):3091.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

The analysis of the LRC-CPPT results was entirely consistent with the hypothesis set forth in the study protocol adopted by the LRC investigators in 1973: "It is postulated that cholesterol reduction with a bile acid sequestrant will produce a significant decrease in the death rate from atherosclerotic coronary heart disease and in the occurrence rate of definite nonfatal myocardial infarction in a group of asymptomatic patients with primary type II hyperlipoproteinemia, also receiving a cholesterol lowering diet, when compared with a diet and placebo treated group." The term "significant" was not defined in terms of a particular statistical probability level.

The statement cited by Drs L'Abbeé, Detsky, and Logan was taken from a published description of the procedure for estimating a sample size sufficient to provide the LRC-CPPT with the statistical power to test this hypothesis. The intent of this statement was to explain to the reader the . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?